Ark Invest has significantly increased its stake in the crypto platform Bullish ($BLSH), buying up millions of dollars in shares over four consecutive days. The heavy buying took place right as the digital asset firm experienced a notable downturn on the New York Stock Exchange ($NYSE). Cathie Wood, who heads the investment firm, capitalised on a broader drop in crypto prices to secure a much cheaper entry point.
Cathie Wood Executes a Rapid Acquisition strategy
Ark Invest added an impressive $5 million worth of BLSH shares to its exchange-traded funds on Thursday alone. This transaction capped off a relentless buying streak that started at the beginning of the week. Daily disclosures reveal that the money manager deployed a total of $12.5 million into the crypto business across the four-day period.
The aggressive accumulation occurred even as the individual stock faced downward pressure, with shares closing down 0.2% at $35.96 on Thursday. This strategy matches the firm’s long-term habit of accumulating high-growth tech stocks whenever short-term market sentiment turns negative.
A Weak Bitcoin Price Creates a Cheap Entry Point
The sudden drop in the BLSH stock price stems from a broader struggle across the entire crypto ecosystem. The equity has tumbled more than 17% over the last two weeks, largely because Bitcoin (BTC-USD) is fighting a tough battle to break past its stubborn $80,000 resistance level.
When major tokens stall out, they naturally drag related crypto stocks down with them. Ark Invest deliberately targets these exact moments of weakness, treating the temporary pullback as a discount on a business they really believe in. The firm stepped in with millions while other investors hesitated, counting on a strong rebound once the broader crypto market clears its current hurdles.
Is Bullish a Good Stock to Buy?
Bullish stock (BLSH) continues to carry a Strong Buy consensus, based on six analyst ratings over the past three months. Out of those, five call it a Buy, while one recommends a Hold. None of the analysts currently suggest selling.
The average 12-month BLSH price target sits at $51.58, which represents 41.4% upside potential.
